CODEINE SULFATE از شرکت HIKMA

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

New Drug Application (NDA): 202245

Company: HIKMA

Medication Guide

Summary Review

Products on NDA 202245

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CODEINE SULFATE	CODEINE SULFATE	30MG/5ML	SOLUTION;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 202245

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/30/2011	ORIG-1	Approval	Type 5 – New Formulation or New Manufacturer	STANDARD	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202245s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202245s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202245_codeine_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202245Orig1s000SumR.pdf

Action Date

Submission

Action Type

Submission Classification

Review Priority; Orphan Status

Letters, Reviews, Labels, Patient Package Insert

Notes

Url

06/30/2011

ORIG-1

Approval

Type 5 – New Formulation or New Manufacturer

STANDARD

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202245s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202245s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202245_codeine_toc.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202245Orig1s000SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Url
03/04/2021	SUPPL-9	Labeling-Package Insert	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202245s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/202245Orig1s009ltr.pdf
10/07/2019	SUPPL-8	Labeling-Package Insert, Labeling-Medication Guide	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202245s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/202245Orig1s008ltr.pdf
09/18/2018	SUPPL-7	Labeling-Package Insert	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202245s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/202245Orig1s006s007ltr.pdf
09/18/2018	SUPPL-6	REMS – PROPOSAL – D-N-A	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202245s006s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/202245Orig1s006s007ltr.pdf
08/29/2017	SUPPL-5	Labeling-Package Insert	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202245s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/202245Orig1s005ltr.pdf
12/16/2016	SUPPL-4	Labeling-Medication Guide, Labeling-Package Insert	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202245s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/202245Orig1s004ltr.pdf
05/09/2013	SUPPL-2	Labeling-Package Insert	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202245s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/202245Orig1s002ltr.pdf
04/17/2012	SUPPL-1	Labeling-Package Insert	Label (PDF) Letter (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202245s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202245s001ltr.pdf

Labels for NDA 202245

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Url
03/04/2021	SUPPL-9	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202245s009lbl.pdf
10/07/2019	SUPPL-8	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202245s008lbl.pdf
10/07/2019	SUPPL-8	Labeling-Medication Guide	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202245s008lbl.pdf
09/18/2018	SUPPL-7	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202245s006s007lbl.pdf
09/18/2018	SUPPL-6	REMS – PROPOSAL – D-N-A	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202245s006s007lbl.pdf
08/29/2017	SUPPL-5	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202245s005lbl.pdf
12/16/2016	SUPPL-4	Labeling-Medication Guide	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202245s004lbl.pdf
12/16/2016	SUPPL-4	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202245s004lbl.pdf
05/09/2013	SUPPL-2	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202245s002lbl.pdf
04/17/2012	SUPPL-1	Labeling-Package Insert	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202245s001lbl.pdf
06/30/2011	ORIG-1	Approval	Label (PDF)	https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202245s000lbl.pdf

منبع : www.accessdata.fda.gov

بخوانید BUTALBITAL, ASPIRIN AND CAFFEINE از شرکت QUANTUM PHARMICS

CODEINE SULFATE از شرکت HIKMA